A drug with the SMILES CCOc1cc(C(=O)N2CCC(CC3CC(c4ccccc4)=NO3)(C(=O)NCc3ccc(OC)cc3)CC2)cc(OCC)c1OCC has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 7.909\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCOc1cc(C(=O)N2CCC(CC3CC(c4ccccc4)=NO3)(C(=O)NCc3ccc(OC)cc3)CC2)cc(OCC)c1OCC
CCOc1cc(C(=O)N2CCC(CC3CC(c4ccccc4)=NO3)(C(=O)NCc3ccc(OC)cc3)CC2)cc(OCC)c1OCC
N-[(4-methoxyphenyl)methyl]-4-[(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)methyl]-1-(3,4,5-triethoxybenzoyl)piperidine-4-carboxamide